Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,016 | 843 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,724 | 118 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,625 | 98 | $0 (2024) |
| ABBVIE INC. | $1,412 | 101 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,282 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,278 | 56 | $0 (2024) |
| Lilly USA, LLC | $1,093 | 65 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $575.86 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $570.51 | 34 | $0 (2024) |
| Amgen Inc. | $541.24 | 31 | $0 (2024) |
| PFIZER INC. | $530.04 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,992 | 159 | AstraZeneca Pharmaceuticals LP ($492.78) |
| 2023 | $2,953 | 169 | ABBVIE INC. ($459.93) |
| 2022 | $2,603 | 162 | GlaxoSmithKline, LLC. ($325.40) |
| 2021 | $2,707 | 196 | GlaxoSmithKline, LLC. ($462.10) |
| 2020 | $1,113 | 73 | Novo Nordisk Inc ($261.76) |
| 2019 | $751.87 | 51 | Amgen Inc. ($130.34) |
| 2018 | $342.00 | 18 | Janssen Pharmaceuticals, Inc ($108.98) |
| 2017 | $553.62 | 15 | Novo Nordisk Inc ($130.92) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Obesity | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Oncology | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.53 | General |
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 577 | 909 | $101,375 | $60,445 |
| 2022 | 9 | 276 | 426 | $49,135 | $28,378 |
| 2021 | 10 | 451 | 581 | $51,370 | $31,763 |
| 2020 | 9 | 232 | 322 | $40,370 | $18,954 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 281 | $31,080 | $16,570 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 151 | $24,245 | $12,394 | 51.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $9,900 | $8,005 | 80.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $6,200 | $5,365 | 86.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 107 | $8,025 | $5,025 | 62.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 41 | 41 | $3,690 | $3,032 | 82.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 84 | $4,620 | $3,018 | 65.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 16 | 16 | $3,200 | $2,288 | 71.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $2,160 | $1,384 | 64.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $3,680 | $1,279 | 34.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 17 | 17 | $850.00 | $667.59 | 78.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 13 | $1,950 | $653.64 | 33.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $855.00 | $559.55 | 65.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 23 | $920.00 | $202.98 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 139 | $22,240 | $11,817 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 130 | $14,470 | $7,696 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,500 | $3,812 | 84.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 36 | $2,620 | $1,578 | 60.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 21 | 21 | $1,890 | $1,475 | 78.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 23 | 23 | $1,035 | $830.84 | 80.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $1,035 | $650.67 | 62.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 11 | 11 | $825.00 | $407.18 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $520.00 | $110.48 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 108 | $17,280 | $9,746 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 120 | $13,310 | $6,777 | 50.9% |
About Dr. Kaitlin Plummer, DO
Dr. Kaitlin Plummer, DO is a Family Medicine healthcare provider based in Steelton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2016. The National Provider Identifier (NPI) number assigned to this provider is 1114378148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kaitlin Plummer, DO has received a total of $14,016 in payments from pharmaceutical and medical device companies, with $2,992 received in 2024. These payments were reported across 843 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,016).
As a Medicare-enrolled provider, Plummer has provided services to 1,536 Medicare beneficiaries, totaling 2,238 services with total Medicare billing of $139,539. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Steelton, PA
- Active Since 06/30/2016
- Last Updated 07/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114378148
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,092
- JARDIANCE (Drug) $852.99
- VRAYLAR (Drug) $667.57
- Kerendia (Drug) $570.51
- FARXIGA (Drug) $527.75
- MOUNJARO (Drug) $493.60
- XARELTO (Drug) $483.44
- Ozempic (Drug) $474.87
- Wegovy (Drug) $452.53
- NURTEC ODT (Drug) $447.94
- UBRELVY (Drug) $421.79
- Saxenda (Drug) $381.71
- QULIPTA (Drug) $369.09
- BREZTRI (Drug) $363.35
- EVENITY (Biological) $314.54
- Vascepa (Drug) $293.50
- XIFAXAN (Drug) $285.06
- STIOLTO RESPIMAT (Drug) $279.44
- ELIQUIS (Drug) $250.50
- Rybelsus (Drug) $202.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Steelton
Daniel Kambic, Do, DO
Family Medicine — Payments: $21,476
Arif Shaikh, Md, MD
Family Medicine — Payments: $3,394
William Wewer, D.o, D.O
Family Medicine — Payments: $3,236
Deanne Endy, Do, DO
Family Medicine — Payments: $1,383
Maryjo Szada, Md, MD
Family Medicine